FireGen Biomedicals

Beijing, China · Founded 2016 · Privately Held (backing)

Provider of cancer screening services intended for oncology treatment. FireGen Biomedicals is based in Beijing, China and was founded in 2016. It has raised $29.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$29.4M
Last round
—
Valuation — not yet established

No valuation for FireGen Biomedicals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($29.4M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of FireGen Biomedicals with a free account
  • ·The complete investor list: 11 names
  • ·Watch FireGen Biomedicals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

FireGen Biomedicals funding history

No rounds on record

No funding rounds for FireGen Biomedicals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How FireGen Biomedicals's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For FireGen Biomedicals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about FireGen Biomedicals

How much has FireGen Biomedicals raised?
FireGen Biomedicals has raised $29.4M in total funding across its recorded rounds.